机器学习能否辅助选择经皮与外科血运重建
本研究基于SYNTAX试验和CREDO-Kyoto注册数据,采用Lasso回归与梯度提升等机器学习算法,整合临床、生物学和解剖因素构建5年死亡预后指数,并联合治疗方式与预设效应修饰因子,评估个体化血运重建决策的可行性。结果显示混合梯度提升模型预测5年全因死亡的C指数在交叉验证为0.78(95%CI:0.75-0.81),外部验证为0.77(95%CI:0.76-0.79),外部验证中区分能力优于SSII-2020,并识别出CABG与PCI治疗获益的异质性。
要点
- 机器学习模型可预测5年死亡并识别血运重建获益异质性。
- 外部验证中模型区分能力优于SSII-2020。
- 需在能采集大量参数的医疗系统中实施以 harmonize 决策。
核心结论
- 基于机器学习的方法识别从CABG或PCI获益的个体是可行且有效的。
研究设计与样本
- 在SYNTAX试验(n=1,800)中开发并交叉验证,在CREDO-Kyoto注册(n=7,362)中进行外部验证,并与SSII-2020比较。
- 使用Lasso回归和梯度提升算法构建5年死亡预后指数,第二阶段联合治疗方式与预设效应修饰因子(疾病类型和解剖SYNTAX评分)。
主要发现
- 混合梯度提升模型预测5年全因死亡的C指数在交叉验证为0.78(95%CI:0.75-0.81),外部验证为0.77(95%CI:0.76-0.79)。
- 机器学习模型在外部验证队列中区分5年死亡率优于SSII-2020。
- 模型识别出CABG与PCI治疗获益的异质性。
临床怎么用
- 该模型可用于辅助三支病变和/或左主干CAD患者选择PCI或CABG的个体化决策。
- 实施需医疗系统训练采集大量参数,可能促进全球决策 harmonization。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with 3-vessel coronary artery disease (CAD) and/or left main CAD, individual risk prediction plays a key role in deciding between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). OBJECTIVES: The aim of this study was to assess whether these individualized revascularization decisions can be improved by applying machine learning (ML) algorithms and integrating clinical, biological, and anatomical factors. METHODS: In the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) study, ML algorithms (Lasso regression, gradient boosting) were used to develop a prognostic index for 5-year death, which was combined, in the second stage, with assigned treatment (PCI or CABG) and prespecified effect-modifiers: disease type (3-vessel or left main CAD) and anatomical SYNTAX score. The model's discriminative ability to predict the risk of 5-year death and treatment benefit between PCI and CABG was cross-validated in the SYNTAX trial (n = 1,800) and externally validated in the CREDO-Kyoto (Coronary REvascularization Demonstrating Outcome Study in Kyoto) registry (n = 7,362), and then compared with the original SYNTAX score II 2020 (SSII-2020). RESULTS: The hybrid gradient boosting model performed best for predicting 5-year all-cause death with C-indexes of 0.78 (95% CI: 0.75-0.81) in cross-validation and 0.77 (95% CI: 0.76-0.79) in external validation. The ML models discriminated 5-year mortality better than the SSII-2020 in the external validation cohort and identified heterogeneity in the treatment benefit of CABG vs PCI. CONCLUSIONS: An ML-based approach for identifying individuals who benefit from CABG or PCI is feasible and effective. Implementation of this model in health care systems-trained to collect large numbers of parameters-may harmonize decision making globally. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NCT03417050; SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries; NCT00114972).
引用
- Ninomiya K, Kageyama S, Shiomi H, et al. Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization? J Am Coll Cardiol. 2023. PMID: 37993203. doi:10.1016/j.jacc.2023.09.818
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。